{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:33:39Z","timestamp":1793054019891,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.nano.2024.102797","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T08:49:23Z","timestamp":1732697363000},"page":"102797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The nanocrystal-loaded liposome of tanshinone IIA with high drug loading and stability towards efficient liver fibrosis reversion"],"prefix":"10.1016","volume":"63","author":[{"given":"Chunyan","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2024.102797_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7514046","article-title":"Therapeutic effect of Tanshinone IIA on liver fibrosis and the possible mechanism: a preclinical Meta-analysis","volume":"2019","author":"Ying","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.nano.2024.102797_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/IJN.S84035","article-title":"Recent insights into the biological activities and drug delivery systems of tanshinones","author":"Chen","year":"2016","journal-title":"IJN"},{"issue":"01","key":"10.1016\/j.nano.2024.102797_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1142\/S0192415X22500070","article-title":"Tanshinone IIA: new perspective on the anti-tumor mechanism of a traditional natural medicine","volume":"50","author":"Zhang","year":"2022","journal-title":"Am J Chin Med"},{"issue":"1","key":"10.1016\/j.nano.2024.102797_bb0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep.32239","article-title":"Liver fibrosis: extracellular vesicles mediated intercellular communication in perisinusoidal space","volume":"76","author":"Devaraj","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.nano.2024.102797_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Asp Med"},{"issue":"1","key":"10.1016\/j.nano.2024.102797_bb0030","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1038\/s41598-018-26828-0","article-title":"Simultaneous purification of dihydrotanshinone, tanshinone I, cryptotanshinone, and tanshinone IIA from salvia miltiorrhiza and their anti-inflammatory activities investigation","volume":"8","author":"Gao","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2024.102797_bb0035","series-title":"Pharmacological Basis of Tanshinone and New Insights into Tanshinone as a T Multitarget Natural Product for Multifaceted Diseases","author":"Li","year":"2020"},{"issue":"7","key":"10.1016\/j.nano.2024.102797_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103229","article-title":"Inhibitory effect of Tanshinone IIA on rat hepatic stellate cells","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2024.102797_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/734987","article-title":"Explore the molecular mechanism of apoptosis induced by Tanshinone IIA on activated rat hepatic stellate cells","volume":"2012","author":"Pan","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.nano.2024.102797_bb0050","doi-asserted-by":"crossref","unstructured":"Xiong C., Zhou H., Wu J., Guo N-Z. The protective effects and the involved mechanisms of Tanshinone IIA on Sepsis-induced brain damage in mice. Inflammation 2019;42(1):354\u201364. Doi:https:\/\/doi.org\/10.1007\/s10753-018-0899-z.","DOI":"10.1007\/s10753-018-0899-z"},{"key":"10.1016\/j.nano.2024.102797_bb0055","doi-asserted-by":"crossref","unstructured":"Hong M., Li S., Wang N., Tan H-Y., Cheung F., Feng Y. A biomedical investigation of the Hepatoprotective effect of Radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets. Int J Mol Sci 2017.","DOI":"10.3390\/ijms18030620"},{"key":"10.1016\/j.nano.2024.102797_bb0060","doi-asserted-by":"crossref","unstructured":"Ashour AA., El-Kamel AH., Abdelmonsif DA., Khalifa HM., Ramadan AA. Modified lipid Nanocapsules for targeted Tanshinone IIA delivery in liver fibrosis. IJN 2021;Volume 16:8013\u201333. Doi:https:\/\/doi.org\/10.2147\/IJN.S331690.","DOI":"10.2147\/IJN.S331690"},{"key":"10.1016\/j.nano.2024.102797_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111404","article-title":"A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment","volume":"137","author":"Bi","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2024.102797_bb0070","doi-asserted-by":"crossref","unstructured":"Shi M-J., Dong B-S., Yang W-N., Su S-B., Zhang H. Preventive and therapeutic role of Tanshinone IIA in hepatology. Biomed Pharmacother 2019;112:108676. Doi:https:\/\/doi.org\/10.1016\/j.biopha.2019.108676.","DOI":"10.1016\/j.biopha.2019.108676"},{"key":"10.1016\/j.nano.2024.102797_bb0075","doi-asserted-by":"crossref","first-page":"1071415","DOI":"10.3389\/fonc.2023.1071415","article-title":"Tanshinone IIA and hepatocellular carcinoma: a potential therapeutic drug","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.nano.2024.102797_bb0080","doi-asserted-by":"crossref","unstructured":"Lu T-C., Wu Y-H., Chen W-Y., Hung Y-C. Targeting oxidative stress and endothelial dysfunction using Tanshinone IIA for the treatment of tissue inflammation and fibrosis. Oxidative Med Cell Longev 2022;2022:1\u201320. Doi:https:\/\/doi.org\/10.1155\/2022\/2811789.","DOI":"10.1155\/2022\/2811789"},{"key":"10.1016\/j.nano.2024.102797_bb0085","doi-asserted-by":"crossref","unstructured":"Xing L., Tan Z-R., Cheng J-L., Huang W-H., Zhang W., Deng W., et al. Bioavailability and pharmacokinetic comparison of tanshinones between two formulations of salvia miltiorrhiza in healthy volunteers. Sci Rep 2017;7(1):4709. Doi:https:\/\/doi.org\/10.1038\/s41598-017-02747-4.","DOI":"10.1038\/s41598-017-02747-4"},{"key":"10.1016\/j.nano.2024.102797_bb0090","doi-asserted-by":"crossref","unstructured":"Ashour AA., Ramadan AA., Abdelmonsif DA., El-Kamel AH. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: formulation, in-vitro appraisal and pharmacokinetics. Int J Pharm 2020;586:119598. Doi:https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119598.","DOI":"10.1016\/j.ijpharm.2020.119598"},{"key":"10.1016\/j.nano.2024.102797_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/IJN.S84035","article-title":"Recent insights into the biological activities and drug delivery systems of tanshinones","author":"Chen","year":"2016","journal-title":"IJN"},{"key":"10.1016\/j.nano.2024.102797_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120418","article-title":"Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy","volume":"599","author":"Liang","year":"2021","journal-title":"Int J Pharm"},{"issue":"14","key":"10.1016\/j.nano.2024.102797_bb0105","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1055\/s-2006-951698","article-title":"Pharmacokinetics, absorption and tissue distribution of Tanshinone IIA solid dispersion","volume":"72","author":"Hao","year":"2006","journal-title":"Planta Med"},{"key":"10.1016\/j.nano.2024.102797_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.actbio.2020.10.003","article-title":"Compositional inhomogeneity of drug delivery liposomes quantified at the single liposome level","volume":"118","author":"Andresen","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2024.102797_bb0115","doi-asserted-by":"crossref","unstructured":"Pattni BS., Chupin VV., Torchilin VP. New developments in liposomal drug delivery. Chem Rev 2015;115(19):10938\u201366. Doi:https:\/\/doi.org\/10.1021\/acs.chemrev.5b00046.","DOI":"10.1021\/acs.chemrev.5b00046"},{"issue":"2","key":"10.1016\/j.nano.2024.102797_bb0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.apsb.2015.11.005","article-title":"Injected nanocrystals for targeted drug delivery","volume":"6","author":"Lu","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nano.2024.102797_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119406","article-title":"Tea saponins as natural stabilizers for the production of hesperidin nanosuspensions","volume":"583","author":"Long","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2024.102797_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.105118","article-title":"Tea saponins as novel stabilizers for the development of diosmin nanosuspensions: optimization and in vitro evaluation","volume":"90","author":"Xie","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.nano.2024.102797_bb0135","doi-asserted-by":"crossref","unstructured":"Polomska A., Gauthier MA., Leroux J. In vitro and in vivo evaluation of PEGylated layer-by-layer polyelectrolyte-coated paclitaxel nanocrystals. Small 2017;13(2):1602066. Doi:https:\/\/doi.org\/10.1002\/smll.201602066.","DOI":"10.1002\/smll.201602066"},{"key":"10.1016\/j.nano.2024.102797_bb0140","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jconrel.2022.03.047","article-title":"All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals","volume":"345","author":"Wu","year":"2022","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.nano.2024.102797_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.apsb.2022.03.026","article-title":"All-stage targeted therapy for the brain metastasis from triple-negative breast cancer","volume":"13","author":"Luo","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"10.1016\/j.nano.2024.102797_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1499","article-title":"Drug nanocrystals for cancer therapy","volume":"10","author":"Miao","year":"2018","journal-title":"WIREs Nanomed Nanobiotechnol"},{"issue":"6","key":"10.1016\/j.nano.2024.102797_bb0155","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1021\/acsami.2c19269","article-title":"Albumin-based Silibinin nanocrystals targeting activated hepatic stellate cells for liver fibrosis therapy","volume":"15","author":"Luo","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2024.102797_bb0160","doi-asserted-by":"crossref","unstructured":"Witika BA., Choonara YE., Demana PH. A SWOT analysis of nano co-crystals in drug delivery: present outlook and future perspectives. RSC Adv 2023;13(11):7339\u201351. Doi:https:\/\/doi.org\/10.1039\/D3RA00161J.","DOI":"10.1039\/D3RA00161J"},{"key":"10.1016\/j.nano.2024.102797_bb0165","doi-asserted-by":"crossref","unstructured":"Yang Q-Q., Cai W-Q., Wang Z-X., Li Y., Zhang Y., Lin X., et al. Structural characteristics, binding behaviors, and stability of ternary nanocomplexes of lecithin, polyvinylpyrrolidone, and curcumin. LWT 2023;175:114489. Doi:https:\/\/doi.org\/10.1016\/j.lwt.2023.114489.","DOI":"10.1016\/j.lwt.2023.114489"},{"issue":"2","key":"10.1016\/j.nano.2024.102797_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.chmed.2022.10.002","article-title":"Preparation of tanshinone IIA self-soluble microneedles and its inhibition on proliferation of human skin fibroblasts","volume":"15","author":"Zhan","year":"2023","journal-title":"Chinese Herbal Medicines"},{"key":"10.1016\/j.nano.2024.102797_bb0175","doi-asserted-by":"crossref","unstructured":"Chonkar AD., Rao JV., Managuli RS., Mutalik S., Dengale S., Jain P., et al. Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation. Eur J Pharm Biopharm 2016;103:179\u201391. Doi:https:\/\/doi.org\/10.1016\/j.ejpb.2016.04.001.","DOI":"10.1016\/j.ejpb.2016.04.001"},{"key":"10.1016\/j.nano.2024.102797_bb0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2024.02.022","article-title":"Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis","volume":"368","author":"Wang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2024.102797_bb0185","doi-asserted-by":"crossref","unstructured":"Wang J., Kong L., Guo R-B., He S-Y., Liu X-Z., Zhang L., et al. Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer's disease. Drug Deliv 2022;29(1):1648\u201362. Doi:https:\/\/doi.org\/10.1080\/10717544.2022.2072543.","DOI":"10.1080\/10717544.2022.2072543"},{"issue":"3","key":"10.1016\/j.nano.2024.102797_bb0190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1208\/s12249-021-01973-4","article-title":"Galactose-modified PH-sensitive Niosomes for controlled release and hepatocellular carcinoma target delivery of Tanshinone IIA","volume":"22","author":"Hu","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.nano.2024.102797_bb0195","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/03639045.2021.1908331","article-title":"Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-\u03baB and ICAM-1 expression","volume":"47","author":"Ye","year":"2021","journal-title":"Drug Dev Ind Pharm"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963424000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963424000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T16:08:45Z","timestamp":1737821325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963424000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"alternative-id":["S1549963424000662"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2024.102797","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The nanocrystal-loaded liposome of tanshinone IIA with high drug loading and stability towards efficient liver fibrosis reversion","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2024.102797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102797"}}